About Monte Rosa Therapeutics, Inc. 
Monte Rosa Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 35 Schemes (28.72%)
Foreign Institutions
Held by 49 Foreign Institutions (5.33%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
13 Million
(Quarterly Results - Sep 2025)
Net Profit:
-27 Million
Pharmaceuticals & Biotechnology
USD 1,496 Million (Micro Cap)
50.00
NA
0.00%
-1.57
8.52%
6.09






